Russo, F.; Ricci, M.; Dadgar, H.; Travascio, L.; De Feo, M.S.; Brunotti, G.; Usmani, S.; Arabi, H.; Anwar, F.M.; Khalaf, A.N.;
et al. PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives. Int. J. Mol. Sci. 2026, 27, 7112.
https://doi.org/10.3390/ijms27167112
AMA Style
Russo F, Ricci M, Dadgar H, Travascio L, De Feo MS, Brunotti G, Usmani S, Arabi H, Anwar FM, Khalaf AN,
et al. PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 2026; 27(16):7112.
https://doi.org/10.3390/ijms27167112
Chicago/Turabian Style
Russo, Francesca, Maria Ricci, Habibollah Dadgar, Laura Travascio, Maria Silvia De Feo, Gabriele Brunotti, Sharjeel Usmani, Hossein Arabi, Farah M. Anwar, Aysar Najeh Khalaf,
and et al. 2026. "PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives" International Journal of Molecular Sciences 27, no. 16: 7112.
https://doi.org/10.3390/ijms27167112
APA Style
Russo, F., Ricci, M., Dadgar, H., Travascio, L., De Feo, M. S., Brunotti, G., Usmani, S., Arabi, H., Anwar, F. M., Khalaf, A. N., Filippi, L., & Cimini, A.
(2026). PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives. International Journal of Molecular Sciences, 27(16), 7112.
https://doi.org/10.3390/ijms27167112